Every material Form 8-K Hawkins has filed with the SEC since July 31, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Hawkins, Inc. reported record second-quarter fiscal 2027 results, with sales up 12% to $313.8 million and diluted EPS up 23% to $1.34 for the quarter ended September 27, 2026. Gross profit rose 13% to $76.6 million, and the company's SG&A and tax rate rose modestly, but profit growth outpaced sales growth for shareholders. The company also said second-half trends should be consistent with the first half, while noting a non-recurring $6.2 million SG&A benefit in the prior-year second half will not recur.
Quarterly sales rose $33.4 million, or 12%, to $313.8 million; Water Treatment sales grew 16% to $175.0 million.
Diluted EPS was $1.34, up $0.25 from $1.08 a year earlier; net income rose 23% to $27.8 million.
Total debt fell to $229.0 million; leverage ratio was 1.22x adjusted EBITDA, down from 1.37x at fiscal 2026 year-end.
Hawkins repurchased $18.6 million of stock in the six months and closed the Dave Symonds & Associates acquisition; Eagle Labs was acquired after quarter end.
Hawkins, Inc. said director Yi "Faith" Tang resigned from its Board of Directors and all board committees, effective immediately, after notifying the company on August 13, 2026. The filing states her resignation was not due to any disagreement with the company on its operations, policies or practices.
Yi "Faith" Tang resigned from the Board of Directors and its committees.
Notice was given on August 13, 2026; the resignation is effective immediately.
The filing states there was no disagreement relating to company operations, policies or practices.
Hawkins reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Sales rose 8% to $315.7 million, a record for the quarter, but net income fell 3% to $28.3 million and diluted EPS fell $0.05 to $1.35, as higher LIFO reserve and freight costs and lower gross margin offset the sales gain. Shareholders see growth in revenue alongside lower profit per share, and the company did not change any guidance in this filing.
Revenue of $315.7 million, up 8% from $293.3 million; all three segments grew more than 5%.
Net income of $28.3 million, down 3%, or $1.35 per diluted share versus $1.40 a year earlier.
Gross profit rose 2% to $74.0 million, but gross margin fell to 23% of sales from 25%.
Adjusted EBITDA, a non-GAAP measure, rose 1% to $56.9 million; the company repurchased $7.0 million of stock and paid $4.0 million in dividends.
Hawkins, Inc. said Shirley A. Rozeboom, Vice President – Stauber, was determined on May 13, 2026 to no longer be an executive officer, effective that day. The company said the change is part of a planned transition tied to a segment reporting realignment, and that Ms. Rozeboom remains employed by the company.
Shirley A. Rozeboom, Vice President – Stauber, no longer designated an executive officer as of May 13, 2026
Change is part of a planned transition linked to realignment of reporting segments, first effective for the fiscal year ended March 29, 2026
Hawkins reported fiscal 2026 sales of $1.08 billion, up 11%, but diluted earnings per share fell 3% to $3.91 and net income fell to $81.5 million from $84.3 million. The company attributed the profit decline mainly to about $16.5 million in higher amortization, interest expense and earnout-related fair value accretion from six acquisitions, and said pro forma EPS would have risen 9%. Management expects fiscal 2027 EPS to grow.
Fourth-quarter sales were $265.9 million, up 8%, while fourth-quarter diluted EPS was $0.74 versus $0.78 a year earlier.
Full-year adjusted EBITDA was $179.0 million, up 6%, and operating cash flow was $144.3 million, up 30%.
Total debt was $244.0 million at fiscal year-end, and the leverage ratio rose to 1.37x from 0.86x.
For fiscal 2027, management expects EPS to grow and an income tax rate of 25% to 27%.
Hawkins, Inc. reported fiscal 2026 third-quarter results for the period ended December 28, 2025. Sales rose 8% to $244.1 million and adjusted EBITDA rose 3% to $34.8 million, but diluted EPS fell to $0.69 from $0.72, which the company attributed mainly to about $5 million of higher amortization and interest expense from its acquisitions.
Sales were $244.1 million, up $17.9 million or 8% from a year earlier, with Water Treatment up 21% and Industrial Solutions up 10%.
Food & Health Sciences sales fell 10% to $70.0 million.
Net income was $14.3 million, or $0.69 per diluted share, versus $15.0 million, or $0.72, a year earlier.
Total debt was $264.0 million at quarter end, and the leverage ratio was 1.47x trailing 12-month adjusted EBITDA.
Hawkins said its Vice President, General Counsel and Secretary, Richard G. Erstad, intends to retire after 17 years in those roles. He is expected to stop serving as an executive officer on December 28, 2025, as the first step of a planned transition, and to remain an employee until May 2026.
Richard G. Erstad notified the company of his retirement intention on December 17, 2025.
He is expected to cease being an executive officer effective December 28, 2025, the end of the third fiscal quarter.
He is expected to stay on as an employee until May 2026 to support a smooth transition.
The filing does not name a successor or describe financial effects.
Hawkins reported record second-quarter fiscal 2026 revenue of $280.4 million, up 14% from a year earlier, led by 21% growth in Water Treatment that included $23 million of sales from acquired businesses. Diluted EPS fell 7% to $1.08 from $1.16, mainly because of $5 million more amortization and interest expense tied to acquisitions, including WaterSurplus. Management expects about $17 million of annualized WaterSurplus-related expense in fiscal 2026 and expects Food and Health Sciences sales to be flat to down in the second half.
Revenue was $280.4 million, up $33.4 million or 14%; Water Treatment sales rose 21% to $150.9 million.
Net income was $22.6 million, or $1.08 per diluted share, versus $24.1 million, or $1.16, a year earlier.
Adjusted EBITDA was $50.4 million, up 9%; the company expects $17 million of annualized WaterSurplus-related expense in fiscal 2026.
Total debt was $279.0 million at September 28, 2025, after repaying $20 million on its line of credit in the quarter.
At its annual meeting held July 30, 2025, Hawkins shareholders elected all eight board nominees and ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending March 29, 2026. Shareholders also approved, on a non-binding advisory basis, the compensation of the company's executive officers. The filing reports votes on routine governance matters and does not describe any change in leadership or company results.
All eight director nominees were elected; James A. Faulconbridge received 13,417,459 for and 1,327,965 withheld votes
Deloitte & Touche LLP ratified as auditor for the fiscal year ending March 29, 2026, with 16,912,506 for, 20,135 against and 3,654 abstentions
Advisory say-on-pay proposal approved with 14,131,359 for, 594,854 against and 19,211 abstentions
Broker non-votes were 2,190,871 on the director and say-on-pay proposals
Hawkins reported record first-quarter fiscal 2026 sales of $293.3 million, up 15% from a year earlier, with growth in all three segments, helped by the WaterSurplus acquisition. Net income rose to $29.2 million, and diluted EPS was $1.40, up $0.02 or 1%, so profit growth was much smaller than sales growth. Management said it expects all three segments to continue growing profitability in fiscal 2026 and gave a full-year effective tax rate estimate of 26-27%.
Sales of $293.3 million, up $37.4 million or 15%; Water Treatment sales up 28% to $149.6 million
Net income of $29.2 million, or $1.40 per diluted share, versus $28.9 million, or $1.38, a year earlier
Adjusted EBITDA of $57.6 million, up 13%; SG&A expenses rose 24% to $31.0 million
Total debt of $299.0 million at quarter end after a net $150 million borrowing to fund the WaterSurplus acquisition
Hawkins reported record fourth-quarter and full-year fiscal 2025 results, with full-year sales up 6% to $974.4 million and diluted EPS up 12% to $4.03. The company expects all segments to grow in fiscal 2026 and revenue to surpass $1 billion, but expects EPS growth to slow due to higher interest and amortization expense.
Fourth-quarter sales rose 10% to $245.3 million and diluted EPS rose to $0.78 from $0.66 a year earlier.
Full-year Water Treatment sales rose 23% to $446.5 million, while Industrial sales fell 7% and Health and Nutrition sales fell 1%.
Net debt ended the year at $143.9 million, with a leverage ratio of 0.86x adjusted EBITDA; the company expects it to fall below 1x by the end of fiscal 2027.
Fiscal 2026 EPS is expected to grow more slowly than in recent years, and the company will report under new segments starting in the first quarter of fiscal 2026.
On April 25, 2025, Hawkins amended its credit agreement with U.S. Bank and other lenders to provide senior secured revolving credit facilities totaling $400.0 million, maturing April 25, 2030. The company drew approximately $150 million to acquire substantially all assets of Surplus Management, Inc. dba WaterSurplus, and the facility is secured by substantially all of its personal property, which shareholders should weigh as added debt.
Second amendment dated April 25, 2025, with U.S. Bank as administrative agent; revolving facilities total $400.0 million
Approximately $150 million drawn to acquire substantially all assets of Surplus Management, Inc. dba WaterSurplus
Facility matures April 25, 2030; Term SOFR margin of 1.0% to 1.85% based on leverage ratio
Covenants require minimum fixed charge coverage of 1.15 to 1.00 and maximum leverage of 3.5 to 1.0, up to 4.0 to 1.0 after certain permitted acquisitions
Hawkins reported fiscal 2025 third-quarter results for the quarter ended December 29, 2024, with sales up 8% and operating income up 14% from a year earlier. Diluted EPS was $0.72, up from $0.71, though the prior-year figure was helped by a $0.08 per share favorable tax adjustment, and management expects continued growth in Water Treatment and Health and Nutrition.
Sales rose $17.7 million, or 8%, to $226.2 million; Water Treatment sales grew 22% to $99.8 million, while Industrial sales fell 1% to $92.0 million.
Net income was $15.0 million, or $0.72 per diluted share, versus $14.9 million, or $0.71, a year earlier.
Operating income was $21.1 million, the company's 27th consecutive quarter of year-over-year operating income growth.
Effective tax rate for the full fiscal year is expected to be approximately 26-27%; total debt was $114.0 million at quarter end.
Hawkins reported fiscal 2025 second-quarter results for the quarter ended September 29, 2024, with sales up 4% to $247.0 million and net income of $24.1 million. Growth came from the Water Treatment segment, which rose 23% on acquisitions, while Industrial and Health and Nutrition sales declined. The company described the quarter as a record for revenue, gross profit, operating income, net income and diluted EPS.
Diluted EPS was $1.16, up $0.06, or 5%, from $1.10 a year earlier.
Water Treatment sales rose $23.6 million, or 23%, to $124.5 million; Industrial sales fell 9% to $89.9 million.
Operating income was $33.7 million; adjusted EBITDA, a non-GAAP measure, was $46.3 million, up 12%.
The company paid down $30 million on its line of credit in the quarter and reported a leverage ratio of 0.65x.
At its July 31, 2024 annual meeting, Hawkins shareholders elected all eight director nominees, ratified Grant Thornton LLP as independent auditor for the fiscal year ending March 30, 2025, and approved executive compensation on an advisory basis. The filing's voting results are administrative and contain no financial figures. The filing's header lists Item 5.02, but its content reports votes under Item 5.07.
Eight directors elected; Faulconbridge had 2,003,313 votes withheld and Spethmann had 141,036
Grant Thornton LLP ratified: 17,402,747 for, 545,877 against, 34,096 abstain
Say-on-pay approved on an advisory basis: 14,988,501 for, 842,981 against, 68,061 abstain
Hawkins reported record first-quarter fiscal 2025 results for the three months ended June 30, 2024, with net income of $28.9 million, or $1.38 per diluted share, up from $1.12 a year earlier. Sales rose 2% to $255.9 million, driven by Water Treatment growth from acquisitions, while Industrial and Health and Nutrition sales declined. For shareholders, profit growth was strong, though the company's total debt rose to $134.0 million after acquisitions and net borrowings.
Net income was $28.9 million, or $1.38 per diluted share, versus $23.4 million, or $1.12 per diluted share, a year earlier.
Sales were $255.9 million, up 2%; Water Treatment sales rose 25% to $117.2 million, while Industrial sales fell 15% to $103.2 million.
Gross profit rose 24% to $64.7 million, and adjusted EBITDA rose 25% to $50.9 million.
Total debt was $134.0 million at quarter end, and the leverage ratio was 0.84x; the company closed two acquisitions in the quarter.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Hawkins filing is on SEC EDGAR ↗. 8-K briefs of other companies →